The Acquisition Of CellGate Has Enabled Progen To Leverage Skills And Capabilities In The United States As Well As Australia |
|
|
Velcera, Inc. (VLCR-OTC: BB) |
|
|
“Velcera has a patented drug delivery technology that is very well suited to pet health, which is a rapidly growing market. When I saw and learned of a technology that would allow pet owners to more easily administer medicines to their pets, I knew it would have a very bright prospect.” - Dennis F. Steadman MS (VLCR) (Interview published June 27, 2008) |
The Most Powerful Name In Corporate News and Information. |
|
CURRENT ISSUE | COVER ARCHIVES | INDEX | CONTACT | FINANCIALS | MARKETING SERVICES | HOME PAGE |
|
Become a member and access our interview with: Dennis F. Steadman MS, CEO (VLCR)
|
|
